Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
For our 15th video in the GRACE Spanish Lung Cancer Library,
Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Institute, Miami, Florida, joined GRACE to discuss the basics of Lung Cancer for Spanish-speaking patients and caregivers. In this video Dr. Hunis speaks about treating later stage small cell lung cancer.
TRANSCRIPTS - Spanish and English
Tratamiento Para el Cáncer de Pulmón de Células Pequeñas en Estadio Avanzado
El tratamiento de cáncer de pulmón en células pequeñas de estadio extensivo es muy distinto al de células pequeñas de estadio temprano. La forma más distinta de tratarlo, es porque los pacientes, en general, no reciben quimioterapia y radioterapia al mismo tiempo en forma concurrente. Se les trata con quimioterapia de forma paliativa y la radioterapia se reserva también de forma paliativa, por ejemplo, si son pacientes que tienen metástasis óseas con dolor o si son pacientes que tienen metástasis en el sistema nervioso central. En pacientes que no tienen enfermedad en sistema nervioso central también se recomienda la radiación profiláctica del cráneo.
Treatment for Small Cell Lung Cancer in Advanced Stage
The treatment for small cell lung cancer in advanced stage is very different than the one used in early stage. The biggest difference, in general, is that these patients don’t receive chemotherapy and radiotherapy at the same time. They are treated with palliative chemotherapy and radiotherapy is saved for palliative cases, like for patients with bone metastasis that have pain or for patients with central nervous system metastasis. In patients that do not have the disease in the central nervous system, they are advised to take prophylactic cranium radiation.
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: